LENIAS HWENDA | Drive to make HIV-prevention shot in SA could reshape industry
Fact-Check Results
“The resurgence of 'America First' industrial policy is reshaping global supply chains”
❓
INSUFFICIENT EVIDENCE
— No relevant evidence found in archive to confirm or refute the claim about global supply chain reshaping by 'America First' policy.
“Countries are treating pharmaceutical production as a strategic capability”
❓
INSUFFICIENT EVIDENCE
— No evidence in archive to verify whether countries treat pharmaceutical production as a strategic capability.
“South Africa has about 7.8-million people living with HIV”
❓
INSUFFICIENT EVIDENCE
— No data in archive to confirm South Africa's HIV prevalence figures.
“About 170,000 new infections are recorded annually in South Africa”
❓
INSUFFICIENT EVIDENCE
— No evidence in archive to verify annual HIV infection rates in South Africa.
“South Africa is attempting to position itself as a manufacturer of lenacapavir”
❓
INSUFFICIENT EVIDENCE
— No information in archive about South Africa's efforts to manufacture lenacapavir.
“Lenacapavir is developed by Gilead Sciences”
❓
INSUFFICIENT EVIDENCE
— No evidence in archive to confirm lenacapavir's development by Gilead Sciences.
“The medicine can be administered as an injection just twice a year”
❓
INSUFFICIENT EVIDENCE
— No data in archive to verify lenacapavir's administration method.
“Daily adherence has long been one of the biggest obstacles to effective prevention programmes”
❓
INSUFFICIENT EVIDENCE
— No evidence in archive to confirm historical challenges with daily adherence to HIV prevention programs.
“South Africa imports 60%-70% of its finished medicines”
❓
INSUFFICIENT EVIDENCE
— No information in archive about South Africa's pharmaceutical imports.
“The pharmaceutical trade deficit exceeds R30bn a year”
❓
INSUFFICIENT EVIDENCE
— No evidence in archive to verify South Africa's pharmaceutical trade deficit figures.
“A phased approach involves importing the active ingredient while doing local formulation and packaging”
❓
PENDING
“South Africa runs one of the world's largest HIV treatment programmes”
❓
PENDING
“Advanced pharmaceutical production requires specialised skills including chemical engineers and regulatory experts”
❓
PENDING
“The main barrier was technical capacity, particularly the ability to manufacture the active pharmaceutical ingredient”
❓
PENDING
“South African companies submitted bids to manufacture lenacapavir in an earlier licensing round”
❓
PENDING
“Long-acting formulations represent one of the fastest-growing areas of pharmaceutical innovation”
❓
PENDING
“Producing lenacapavir at scale demands sophisticated facilities and strict regulatory oversight”
❓
PENDING
“South Africa's pharmaceutical market is worth about R70bn a year”
❓
PENDING
“The Covid-19 pandemic exposed the risks embedded in the current model”
❓
PENDING
“SANAC is coordinating a renewed effort to identify a local manufacturer for lenacapavir”
❓
PENDING
“Eva Pharma in Egypt has been granted a licence to produce lenacapavir”
❓
PENDING